Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Although Mdm2-mediated ubiquitination is essential for both degradation and nuclear export of p53, the molecular basis for the differential effects of Mdm2 remains unknown. Here we show that low levels of Mdm2 activity induce monoubiquitination and nuclear export of p53, whereas high levels promote p53's polyubiquitination and nuclear degradation. A p53-ubiquitin fusion protein that mimics monoubiquitinated p53 was found to accumulate in the cytoplasm in an Mdm2-independent manner, indicating that monoubiquitination is critical for p53 trafficking. These results clarify the nature of ubiquitination-mediated p53 regulation and suggest that distinct mechanisms regulate p53 function in accordance with the levels of Mdm2 activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“proteasome inhibition by ALLN stabilizes p53 mainly in the nucleus of RKO cancer cells, whereas cytoplasmic p53 accumulates to a far lower extent”
From Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding (2010) · cites this paper as [23]
In the citing paper
“Interestingly, although p53 nuclear import is negatively regulated by ubiquitin modification, p53 nuclear export as well as translocation of cytoplasmic p53 to mitochondria are positively regulated by ubiquitin.23,37,38”
From Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding (2010) · cites this paper as [23]
In the citing paper
“Interestingly, although p53 nuclear import is negatively regulated by ubiquitin modification, p53 nuclear export as well as translocation of cytoplasmic p53 to mitochondria are positively regulated by ubiquitin.23,37,38”
From Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding (2010) · cites this paper as [23]
In the citing paper
“Additionally, mono-ubiquitination of p53 can facilitate export of p53 from the nucleus to the cytoplasm, thereby inhibiting its role as a transcription factor [110,111].”
From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [111]
In the citing paper
“However, proteasome-dependent degradation of nuclear p53 can also effectively prevent its transactivation function [111,112], suggesting monoubiquitylation of cytoplasmic p53 is required for other processes.”
From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [111]
Citations
Cites
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Mechanisms Underlying Ubiquitination
Pickart, C. M. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.503 · Cited by 3,184
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951
Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53
Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H., & Weissman, A. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8945 · Cited by 1,044
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization
Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J., & Gu, W. (2002) · Nature · doi:10.1038/nature737 · Cited by 1,031
Self-citationStommel, J. M., Marchenko, N. D., Jimenez, G. S., Moll, U. M., Hope, T. J., & Wahl, G. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1660 · Cited by 738
Pirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 Degradation
Leng, R. P., Lin, Y., Ma, W., Wu, H., Lemmers, B., Chung, S., Parant, J. M., Lozano, G., Hakem, R., & Benchimol, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00193-4 · Cited by 722
Generation of oscillations by the p53-Mdm2 feedback loop: A theoretical and experimental study
Lev Bar-Or, R., Maya, R., Segel, L. A., Alon, U., Levine, A. J., & Oren, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.210171597 · Cited by 588
Cited by
Items 501–600 of 797
P53 mediates estradiol induced activation of apoptosis and DNA repair in non-malignant colonocytes
Weige, C. C., Allred, K. F., Armstrong, C. M., & Allred, C. D. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.10.010 · Cited by 22
A High-Throughput Screen Measuring Ubiquitination of p53 by Human mdm2
Murray, M. F., Jurewicz, A. J., Martin, J. D., Ho, T. F., Zhang, H., Johanson, K., Kirkpatrick, R. B., Ma, J., Lor, L. A., Thrall, S. H., et al. (2007) · SLAS DISCOVERY · doi:10.1177/1087057107308556 · Cited by 25
“There is conflicting evidence whether mdm2 itself (at higher concentrations) or other E3 ligases (such as p300) are responsible for the polyubiquitination of p53 needed for efficient degradation in vivo.(17,18) We FRET signal(s)”
BackgroundMethodHuang, M., Wu, Y., Wei, X., Cheng, L., Fu, L., Yan, H., Wei, W., Li, B., Ru, H., Mo, X., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07541-z · Cited by 24
MDM2 Mediates Nonproteolytic Polyubiquitylation of the DEAD-Box RNA Helicase DDX24
Yamauchi, T., Nishiyama, M., Moroishi, T., Yumimoto, K., & Nakayama, K. I. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00320-14 · Cited by 24
“Direct fusion of a ubiquitin moiety to p53 was previously shown to alter the subcellular distribution of p53 in a manner similar to that apparent after its posttranslational monoubiquitylation (54).”
BackgroundFunctional mimicry of the acetylated C‐terminal tail of p53 by a SUMO‐1 acetylated domain, SAD
Cheema, A. K., Knights, C. D., Rao, M., Catania, J., Perez, R. E., Simons, B. L., Dakshanamurthy, S., Kolukula, V. K., Tilli, M. T., Furth, P. A., et al. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22224 · Cited by 23
“An identical strategy was employed by others to assess the effects of p53 mono-ubiquitination or of histone H4 sumoylation (Li et al., 2003; Shiio and Eisenman, 2003).”
E2 Ligase dRad6 Regulates DMP53 Turnover in Drosophila
Chen, S., Wei, H.-M., Lv, W., Wang, D.-L., & Sun, F.-L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.190314 · Cited by 24
Ubiquitin and transcription: The SCFMet30/Met4 pathway, a (protein-) complex issue
Ouni, I., Flick, K. M., & Kaiser, P. (2011) · Transcription · doi:10.4161/trns.2.3.15903 · Cited by 21
Volk, E. L., Schuster, K., Nemeth, K. M., Fan, L., & Harris, L. C. (2008) · Disease Models & Mechanisms · doi:10.1242/dmm.000992 · Cited by 20
“Inhibition of p53 by MDM2 results in strict control of p53 protein levels through MDM2-mediated ubiquitylation and proteasomal degradation (Li et al., 2003).”
BackgroundWang, X., Zhang, Y., Lü, P., Zhang, H., Li, Y., Dong, H., & Zhang, Z. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.08.015 · Cited by 20
Zheng, Y., Wang, L., Niu, X., Guo, Y., Zhao, J., Li, L., & Zhao, J. (2023) · BMC Cancer · doi:10.1186/s12885-023-10506-0 · Cited by 21
“Some USP family members have been shown to regulate the p53 pathway [33, 34].”
BackgroundInsulin Receptor Tyrosine Kinase Substrate Enhances Low Levels of MDM2-Mediated p53 Ubiquitination
Wang, K., Chen, G., Shen, H., Li, T., Chen, F., Wang, Q.-W., Wang, Z., Han, Z., & Zhang, X. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023571 · Cited by 20
“. MDM2, a key regulator of p53, catalyzes both monoubiquitination and polyubiquitination on p53 in a dose-dependent manner. High levels of MDM2 mediate p53 polyubiquitination and proteasomal degradation, whereas low levels of MDM2 induce the monoubiquitination and nuclear export of p53”
Chan, W. M., & Poon, R. Y. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3602 · Cited by 19
“Although p53 can be ubiquitinated by MDM2 inside the nucleus ( 42 ), one major pathway of p53 degradation is through the export of the p53-MDM2 complexes to the cytoplasm before p53 is delivered to the ubiquitin/proteasome pathway.”
BackgroundMechanisms for human cytomegalovirus-induced cytoplasmic p53 sequestration in endothelial cells
Utama, B., Shen, Y. H., Mitchell, B., Makagiansar, I. T., Gan, Y., Muthuswamy, R., Duraisamy, S., Martin, D., Wang, X., Zhang, M., et al. (2006) · Journal of Cell Science · doi:10.1242/jcs.02974 · Cited by 19
“6 and above) will poly-ubiquitinate p53 (Li et al., 2003).”
BackgroundInfluentialSelf-citationThe Ubiquitinated Axon: Local Control of Axon Development and Function by Ubiquitin
Pinto, M. J., Tomé, D., & Almeida, R. D. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2251-20.2021 · Cited by 23
“Ubiquitination can also alter, either directly or indirectly, several properties of the tagged protein itself, including activity, location, or propensity to interact with partners (Laub et al., 1998; Li et al., 2003; DuPont et al., 2009; Sasaki et al., 2011; Baker et al., 2013; Wang et al., 2018).”
BackgroundNuclear transport surveillance of p53 by nuclear pores in glioblastoma
Ikliptikawati, D. K., Hirai, N., Makiyama, K., Sabit, H., Kinoshita, M., Matsumoto, K., Lim, K., Meguro‐Horike, M., Horike, S., Hazawa, M., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112882 · Cited by 21
de Sousa, H. M. L., Pando, M., Breda, E. R., Catarino, R., & Medeiros, R. (2010) · Molecular Carcinogenesis · doi:10.1002/mc.20689 · Cited by 22
Phosphorylation of p53 at threonine 155 is required for Jab1-mediated nuclear export of p53
Lee, E., Oh, W., Song, H. P., & Kim, W. K. (2017) · BMB Reports · doi:10.5483/bmbrep.2017.50.7.077 · Cited by 22
Martinho, M. S., Nancarrow, D. J., Lawrence, T. S., Beer, D. G., & Ray, D. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.10.012 · Cited by 20
Selective protein degradation in cell signalling
Liu, H., Urbé, S., & Clague, M. J. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.01.014 · Cited by 19
“Only the latter specifies cellular egradation, whilst monoubiquitylation leads to nuclear export of 53 [91].”
BackgroundTickets for p53 journey among organelles
Ferecatu, I., Rincheval, V., Mignotte, B., & Vayssiere, J.-L. (2009) · Frontiers in bioscience · doi:10.2741/3524 · Cited by 19
“Some studies have shown that Mdm2-mediated monoubiquitination exports p53 from the nucleus into the cytoplasm (76, 77).”
BackgroundStructure and function of MDM2 and MDM4 in health and disease
Zhu, I. Y., Lloyd, A., Critchley, W. R., Saikia, Q., Jade, D., Divan, A., Zeqiraj, E., Harrison, M. A., Brown, C. J., & Ponnambalam, S. (2025) · Biochemical Journal · doi:10.1042/bcj20240757 · Cited by 29
“In MDM-mediated p53 ubiquitination, the outcome can lead to either protein degradation or nuclear export depending on MDM2 levels; low MDM2 levels cause p53 monoubiquitination, but high levels promote polyubiquitination [73].”
Wu, L., Crawley, C. D., Garofalo, A., Nichols, J. W., Campbell, P.-A., Khramtsova, G. F., Olopade, O. I., Weichselbaum, R. R., & Yamini, B. (2020) · Nature Communications · doi:10.1038/s41467-020-18838-2 · Cited by 17
Signaling Pathways Involved in Megakaryocyte‐Mediated Proliferation of Osteoblast Lineage Cells
Cheng, Y., Streicher, D. A., Waning, D. L., Chitteti, B. R., Gerard-O’Riley, R. L., Horowitz, M. C., Bidwell, J. P., Pavalko, F. M., Srour, E. F., Mayo, L. D., et al. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24774 · Cited by 18
“Together with the RGDS data, the activating antibody data suggest that b1 integrin signaling is upstream of cell cycle regulators p53 and Rb. Activation of the p38/MAPKAPK2/p90RSK pathway in megakaryocyte-stimulated osteoblasts For Mdm2 to function as a ubiquitinating enzyme, it must receive activation signals from ki…”
BackgroundInfluentialZinc Finger 280B Regulates sGCα1 and p53 in Prostate Cancer Cells
Gao, S., Hsieh, C.-L., Zhou, J., & Shemshedini, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078766 · Cited by 16
Shi, X., Liu, J., Ren, L., Mao, N., Tan, F., Ding, N., Yang, J., & Li, M. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.4.146 · Cited by 17
Self-citationStrategy and Tactics for Designing Analogs: Biochemical Characterization of the Large Molecules
Ahn, J., Kassees, K., Lee, T.-K., Manandhar, B., & Yousif, A. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12413-8 · Cited by 24
DBC1 Regulates p53 Stability via Inhibition of CBP-Dependent p53 Polyubiquitination
Akande, O., Damle, P. K., Pop, M. S., Sherman, N. E., Szomju, B. B., Litovchick, L., & Grossman, S. R. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.076 · Cited by 29
“Early studies have indicated that MDM2 catalyzes multiple monoubiquitination of p53, a signal for p53 nuclear export (Li et al., 2003; Brooks et al., 2004).”
BackgroundMaking Connections: p53 and the Cathepsin Proteases as Co-Regulators of Cancer and Apoptosis
Soond, S. M., Savvateeva, L. V., Makarov, V. A., Gorokhovets, N. V., Townsend, P. A., & Zamyatnin, A. A. (2020) · Cancers · doi:10.3390/cancers12113476 · Cited by 18
“ubiquitination can also behave as a signal for p53 to be cytoplasmically [18,19] or mitochondrially”
BackgroundProtein of a thousand faces: The tumor-suppressive and oncogenic responses of p53
Marques, M. A., de Andrade, G. C., Silva, J. L., & de Oliveira, G. A. P. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.944955 · Cited by 16
“Contrastingly, when MDM2 activity is high, p53 polyubiquitination leads to nuclear degradation (Li et al., 2003).”
BackgroundOrphan Nuclear Receptor PNR/NR2E3 Stimulates p53 Functions by Enhancing p53 Acetylation
Wen, Z. H., Pyeon, D., Wang, Y., Lambert, P. F., Xu, W., & Ahlquist, P. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.05513-11 · Cited by 17
“MDM2, a major regulator of p53 stability, also blocks the transactivation domain of p53 and enhances p53 nuclear export (12, 13, 20).”
BackgroundMDM2, MDM2-C, and mutant p53 expression influence breast cancer survival in a multiethnic population
Loo, L. W. M., Gao, C., Shvetsov, Y. B., Okoro, D. R., Hernandez, B. Y., & Bargonetti, J. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-5065-7 · Cited by 16
Progress in Anticancer Drug Development Targeting Ubiquitination-Related Factors
Li, Q., & Zhang, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315104 · Cited by 19
“MDM2 can also modify p53 via poly-Ub chain for degradation in the nucleus [75,76].”
BackgroundUSP47 deubiquitylates Groucho/TLE to promote Wnt–β-catenin signaling
Kassel, S. N., Hanson, A. J., Benchabane, H., Saito‐Diaz, K., Cabel, C. R., Goldsmith, L., Taha, M., Kanuganti, A., Ng, V. H., Xu, G. J., et al. (2023) · Science Signaling · doi:10.1126/scisignal.abn8372 · Cited by 16
Controlled Access of p53 to the Nucleus Regulates Its Proteasomal Degradation by MDM2
Davis, J. R., Mossalam, M., & Lim, C. S. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300543t · Cited by 19
The antagonism between MCT-1 and p53 affects the tumorigenic outcomes
Kasiappan, R., Shih, H.-J., Wu, M.-H., Choy, C.-O., Lin, T., Chen, L., & Hsu, H.-L. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-311 · Cited by 18
“But Pirh2, MDM2, and Cop1 are ubiquitin ligases implicated in tumor development that mediate p53 degradation in a proteosome manner [9,10,15].”
BackgroundIrisarri, M., Lavista-Llanos, S., Romero, N. M., Centanin, L., Dekanty, A., & Wappner, P. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-01-0038 · Cited by 17
“Interestingly, monoubiquitination promotes p53 nuclear export and polyubiquitination leads to proteasomal degradation ( Li et al., 2003 ).”
BackgroundRoles of mono-ubiquitinated Smad4 in the formation of Smad transcriptional complexes
Wang, B., Suzuki, H., & Kato, M. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.08.143 · Cited by 15
“In a similar manner, p53-Ubiquitin was found to accumulate in the cytoplasm [29], indicating that mono-ubiquitination regulates Smad4 and p53 trafficking.”
BackgroundThe Janus Face of p53-Targeting Ubiquitin Ligases
Hao, Q., Chen, Y., & Zhou, X. Y. (2020) · Cells · doi:10.3390/cells9071656 · Cited by 16
“Second, MDM2 also mediates mono-ubiquitination of p53, leading to translocation of p53 to the cytoplasm and abrogation of its transcriptional activity [33].”
BackgroundWild‐type p53 enhances annexin IV gene expression in ovarian clear cell adenocarcinoma
Masuishi, Y., Arakawa, N., Kawasaki, H., Miyagi, E., Hirahara, F., & Hirano, H. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08059.x · Cited by 15
Fusing DEDD with ubiquitin changes its intracellular localization and apoptotic potential
Lee, J. C., Wang, G., Schickling, O., & Peter, M. E. (2005) · APOPTOSIS · doi:10.1007/s10495-005-1833-z · Cited by 17
Schutter, J. D. D., Guillabert, A., Imbault, V., Degraef, C., Erneux, C., Communi, D., & Pirson, I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.064923 · Cited by 16
P53, Cell Cycle Arrest and Apoptosis
Wang, S., & El‐Deiry, W. S. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_6 · Cited by 18
Dissecting Roles of Ubiquitination in the p53 Pathway
Shan, J., Brooks, C. L., Kon, N., Li, M., & Gu, W. J. (2008) · Ernst Schering Research Foundation workshop/Ernst Schering Foundation Symposium proceedings · doi:10.1007/2789_2008_105 · Cited by 15
Self-citationFriend or foe? Reciprocal regulation between E3 ubiquitin ligases and deubiquitinases
Bolhuis, D. L., Emanuele, M. J., & Brown, N. G. (2024) · Biochemical Society Transactions · doi:10.1042/bst20230454 · Cited by 16
p53 Detection by Fluorescence Lifetime on a Hybrid Fluorescein Isothiocyanate Gold Nanosensor
Sironi, L., Freddi, S., D’Alfonso, L., et al. (2009) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2009.1085 · Cited by 14
A bioluminescent assay for monitoring conjugation of ubiquitin and ubiquitin-like proteins.
Mondal, S., Hsiao, K., & Goueli, S. (2016) · Analytical Biochemistry · doi:10.1016/j.ab.2016.06.016 · Cited by 12
Wu, J., Wang, H., Li, Q., Guo, Q., Tao, S.-Q., Shen, Y., & Wu, Z. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.152523 · Cited by 14
Hyperglycemia promotes p53-Mdm2 interaction but reduces p53 ubiquitination in RINm5F cells
Barzalobre-Geronimo, R., Flores-López, L. A., Baiza-Gutman, L. A., Cruz, M., García-Macedo, R., Ávalos‐Rodríguez, A., Contreras‐Ramos, A., Díaz-Flores, M., & Ortega‐Camarillo, C. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2416-0 · Cited by 15
“Mdm2 is an E3 ubiquitin ligase that binds to p53 and attaches ubiquitin molecules, allowing for p53 to be recognized by the proteasome for degradation and protecting cells from apoptosis [10, 11].”
Proteasome dynamics in response to metabolic changes
Enenkel, C., & Ernst, O. P. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1523382 · Cited by 15
Targeted β‐catenin ubiquitination and degradation by multifunctional stapled peptides
Wang, X., Dong, L., Cheng, J., Verdine, G. L., Lin, A., & Chu, Q. (2021) · Journal of Peptide Science · doi:10.1002/psc.3389 · Cited by 14
“The ubiquitination pattern with MSA-2 peptide (Lane 3) does not necessarily indicate poly-ubiquitination of β-catenin, because mono-ubiquitination at multiple sites on the protein would also generate the same pattern.(40) To rule out this possibility, we replaced ubiquitin in the reaction with methylated ubiquitin (Me…”
MethodRomani, A., Zauli, E., Zauli, G., Al-Mesfer, S., Al-Swailem, S. A., & Voltan, R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1000677 · Cited by 16
Huang, C.-Y. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.938 · Cited by 13
Mechanisms of p53 Functional De-Regulation: Role of the IκB-α/p53 Complex
Carrà, G., Crivellaro, S., Taulli, R., Guerrasio, A., Saglio, G. N., & Morotti, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17121997 · Cited by 18
“In particular, it was demonstrated that low levels of Mdm2 activity dictate p53 mono-ubiquitination, while high levels promote polyubiquitination [53].”
TBP-like Protein (TLP) Disrupts the p53-MDM2 Interaction and Induces Long-lasting p53 Activation
Maeda, R., Tamashiro, H., Takano, K., Takahashi, H., Suzuki, H., Saito, S., Kojima, W., Adachi, N., Ura, K., Endo, T., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.763318 · Cited by 12
A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo
Comiskey, D. F., Jacob, A. G., Sanford, B. L., Montes, M., Goodwin, A., Steiner, H. E., Matsa, E., Tapia-Santos, A. S., Bebee, T. W., Grieves, J. L., et al. (2017) · Oncogene · doi:10.1038/onc.2017.282 · Cited by 16
Role of Ubiquitin and SUMO in Intracellular Trafficking
Sundvall, M. (2019) · Current Issues in Molecular Biology · doi:10.21775/cimb.035.099 · Cited by 15
HAUSP-regulated switch from auto- to p53 ubiquitination by Mdm2 (in silico discovery)
Brazhnik, P., & Kohn, K. W. (2007) · Mathematical Biosciences · doi:10.1016/j.mbs.2007.05.005 · Cited by 16
Jin, X., Chandrakanthan, V., Morgan, H. D., & O’Neill, C. (2009) · Biology of Reproduction · doi:10.1095/biolreprod.109.078444 · Cited by 14
Li, C., Lee, H., Jung, J. H., Zhang, Y.-W., Wang, J., Liu, C., Sheffmaker, R. L., Segall, A. M., Zeng, S. X., & Lu, H. (2022) · Oncogene · doi:10.1038/s41388-022-02541-1 · Cited by 12
“Hence, these results suggest that CCDC3 also stabilizes and activates p53 in the nucleus by preventing it from proteolytic degradation, as monoubiquitinated p53 was shown to be exported to the cytoplasm for degradation [42].”
BackgroundRole of the ubiquitin–proteasome system on macrophages in the tumor microenvironment
Xiao, Y., Liu, R., Li, N., Li, Y., & Huang, X. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31180 · Cited by 13
“MDM2 mediates p53 monoubiquitination and cytoplasmic translocation at low levels, while the elevated activity of MDM2 targets p53 for proteasomal degradation, thereby inhibiting p53 ‐ mediated translocation activation (Li et al., 2003).”
BackgroundPin1-Catalyzed Conformation Changes Regulate Protein Ubiquitination and Degradation
Jeong, J., Usman, M., Li, Y., Zhou, X. Z., & Lu, K. P. (2024) · Cells · doi:10.3390/cells13090731 · Cited by 16
“High Pin1 is associated with p53 monoubiquitination and nuclear export, while Pin1 inhibition results in the polyubiquitination of p53 by Mdm2 and subsequent degradation [132].”
BackgroundJo, E. B., Hong, D.-P., Lee, Y. S., Lee, H., Park, J. B., & Kim, S. J. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.09.015 · Cited by 12
Shelly, K. R., Golovich, E. C., Dillman, K. L., & Beck, W. F. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp077103p · Cited by 12
Turinetto, V., Porcedda, P., Minieri, V., Orlando, L., Lantelme, E., Accomasso, L., Amoroso, A., Marchi, M., Zannini, L., Delia, D., et al. (2010) · DNA repair · doi:10.1016/j.dnarep.2010.09.003 · Cited by 11
Mechanisms involved in p53 downregulation by leptin in trophoblastic cells
Toro, A. R., Pérez‐Pérez, A., Corrales-Gutiérrez, I., Sánchez‐Margalet, V., & Varone, C. L. (2015) · Placenta · doi:10.1016/j.placenta.2015.08.017 · Cited by 12
“For example, low MDM-2 levels induce monoubiquitination and nuclear export of p53, while higher levels promote its polyubiquitination and degradation [58].”
BackgroundThe Nucleolus as a Stress Response Organelle
Lindström, M. S., & Latonen, L. (2013) · Springer eBooks · doi:10.1007/978-94-007-5818-6_11 · Cited by 13
p53 – ein natürlicher Krebskiller: Einsichten in die Struktur und Therapiekonzepte
Römer, L., Klein, C., Dehner, A., Kessler, H., & Büchner, J. (2006) · Angewandte Chemie · doi:10.1002/ange.200600611 · Cited by 16
E3 Ubiquitin Ligases: Structures, Biological Functions, Diseases, and Therapy
Wang, H., Peng, J., Li, H., Lan, Y., Guo, J., Qiu, Q., & Huang, X. (2025) · MedComm · doi:10.1002/mco2.70528 · Cited by 17
“The N-terminal domain of MDM2 binds to p53, thereby inhibiting its transcriptional activity [111].”
Ubiquitin recruiting chimera: more than just a PROTAC
Grigoreva, T. A., Novikova, D., Melino, G., Barlev, N. A., & Tribulovich, V. G. (2024) · Biology Direct · doi:10.1186/s13062-024-00497-8 · Cited by 12
“Protein monoubiquitinylation, depending on the target and site, can lead to transcriptional repression/activation, nuclear import/export, inhibition/activation of the target interaction with proteins, lipids and DNA [85–88].”
BackgroundAberrant activation of p53 due to loss of MDM2 or MDMX causes early lens dysmorphogenesis
Zhang, Y.-W., Zhang, X., & Lu, H. (2014) · Developmental Biology · doi:10.1016/j.ydbio.2014.09.017 · Cited by 10
“Through mechanisms that still remain debated, MDMX is shuttled from the cytoplasm into the nucleus (Elias et al., 2005; Gu et al., 2002; Li et al., 2002; Migliorini et al., 2002), where it binds to and works together with MDM2 to inactivate p53 (Li et al., 2003; Wang and Jiang, 2012).”
BackgroundMice defective in p53 nuclear localization signal 1 exhibit exencephaly
Regeling, A., Armata, H. L., Gallant, J., Jones, S. N., & Sluss, H. K. (2010) · Transgenic Research · doi:10.1007/s11248-010-9468-4 · Cited by 11
“The site in the NLS1 is also a site for ubiquitination, therefore, it is possible the protein is not receiving the proper signal for degradation, such as mono-ubiquitination by Mdm2 (Li et al. 2003).”
BackgroundInfluentialTargeted Therapy for EBV-Associated B-cell Neoplasms
Ganguly, S., Kuravi, S., Alleboina, S., Mudduluru, G., Jensen, R. A., McGuirk, J. P., & Balusu, R. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0924 · Cited by 11
COP1 Contributes to UVB-Induced Signaling in Human Keratinocytes
Kinyó, Á., Kiss-László, Z., Hambalkó, S., Bebes, A., Kiss, M., Széll, M., Bata‐Csörgõ, Z., Nagy, F., & Kemény, L. V. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.286 · Cited by 15
TIP30 Directly Binds p53 Tumor Suppressor Protein In Vitro
Lee, S., Ju, S.-K., Lee, T. Y., et al. (2012) · Molecules and Cells · doi:10.1007/s10059-012-0232-x · Cited by 10
“…stimulates p53 mRNA translation by binding p53 mRNA (Naski et al., 2009), but also physically interacts with the N-terminal transcriptional activation domain (TAD) of p53 protein (Chen et al., 1993; Chi et al., 2005) that leads to p53 polyubiquitination and degradation of p53 (Li et al., 2003).”
BackgroundLi, X., He, W., Hou, W.-H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8975 · Cited by 10
Wang, H., Deng, L., Cai, M., Zhuang, H., Zhu, L., Hao, Y., Gao, J., Liu, J., Xiao, L., & Lin, B. (2016) · Oncotarget · doi:10.18632/oncotarget.10226 · Cited by 10
“The resulting increased expression of MDM2 can degrade wild-type p53 protein or inhibit wild-type p53 transcriptional activation by proteolysis, providing negative feedback and regulation of wild-type p53 expression, then promotes tumor growth [17].”
BackgroundThe role of ubiquitination in spinal and bulbar muscular atrophy
Sengupta, M., Pluciennik, A., & Merry, D. E. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1020143 · Cited by 7
Liu, X., Lu, R., Yang, Q., He, J., Huang, C., Cao, Y., Zhou, Z., Huang, J., Li, L., Chen, R., et al. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13543 · Cited by 10
“MDM2 is considered a potential target for cancer therapy because of its negative regulatory role on p53 [48,49].”
BackgroundMémin, E., Genzale, M., Crow, M. S., et al. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.07.001 · Cited by 9
Lai, C. W., Xie, C., Raufman, J., & Xie, G. (2022) · Cancers · doi:10.3390/cancers14010219 · Cited by 10
Jung, J. W., Bae, S. J., Kang, G., Kim, K., Yeo, W., Park, S., Seol, J. H., Yi, E. C., & Kim, K. P. (2012) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.6447 · Cited by 9
Abdelmoula-Souissi, S., Delahodde, A., Bolotin‐Fukuhara, M., Gargouri, A. F., & Mokdad‐Gargouri, R. (2011) · APOPTOSIS · doi:10.1007/s10495-011-0607-z · Cited by 11
Transduction of Recombinant M3-p53-R12 Protein Enhances Human Leukemia Cell Apoptosis
Lu, T.-C., Zhao, G. H., Chen, Y. Y., Chien, C.-Y., Huang, C.-H., Lin, K., & Chen, S. L. (2016) · Journal of Cancer · doi:10.7150/jca.15155 · Cited by 9
Nelson, D. M., Bhaskaran, V. M., Foster, W. R., & Lehman‐McKeeman, L. D. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl115 · Cited by 11
“, 1992), controls p53 levels by functioning as an E3 ubquitin ligase, conjugating ubiquitin monomers to multiple lysine residues within the COOH terminus of p53 and marking the protein for nuclear export and subsequent degradation (Li et al., 2003; Tau and Levine, 1999; Boyd et al., 2000).”
BackgroundCytoplasmic Translocation of p53 by Human Cytomegalovirus Infection
Kwon, Y., Kim, J., Kim, J. H., & Hwang, E. S. (2013) · Journal of Bacteriology and Virology · doi:10.4167/jbv.2013.43.4.297 · Cited by 8
Lee, C. H., Nguyen, T. M., Lee, Y., Choi, S. G., Nguyễn, P. N., Park, J. H., & Park, M. K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010357 · Cited by 15
“Conversely, high levels of MDM2 activity promote the polyubiquitination of p53, leading to its degradation within the nucleus [16].”
Complementary omics strategies to dissect p53 signaling networks under nutrient stress
Galhuber, M., Michenthaler, H., Heininger, C., Reinisch, I., Nössing, C., Krstić, J., Kupper, N., Moyschewitz, E., Auer, M., Heitzer, E., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04345-8 · Cited by 11
“Functioning as a p53 inhibitor, MDM2 directly binds to the N-terminal region of p53, causing p53 ubiquitination followed by p53 nuclear export, proteasomal degradation, or transactivation potential inhibition [11, 12].”
BackgroundThe SWIB/MDM2 motif of UBE4B activates the p53 pathway
Wu, H. H., Leng, S., Abuetabh, Y., Sergi, C. M., Eisenstat, D. D., & Leng, R. P. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.02.002 · Cited by 9
UBE1C is upregulated and promotes neddylation of p53 in lung cancer
Liu, H., Shih, Y., Wang, W., Chang, W., & Wang, Y. (2023) · The FASEB Journal · doi:10.1096/fj.202300629r · Cited by 8
Commitment of protein p53 and amyloid-beta peptide (Aβ) in aging of human cerebellum
Maślińska, D., Laure‐Kamionowska, M., Szukiewicz, D., Maśliński, S., & Księżopolska-Orłowska, K. (2017) · Folia Neuropathologica · doi:10.5114/fn.2017.68583 · Cited by 10
Mandal, K., Tomar, S. K., & Santra, M. K. (2024) · Gene · doi:10.1016/j.gene.2024.148218 · Cited by 9
Ubiquitin E3 ligases controlling p53 stability
Lee, S. W., Seong, M. W., Jeon, Y. J., & Chung, C. H. (2012) · Animal Cells and Systems · doi:10.1080/19768354.2012.688769 · Cited by 11
“Remarkably, the relative amount of Mdm2 is important to decide the fate of ubiquitinated p53 between proteasome- mediated destruction and translocation to the cyto- plasm (Li et al. 2003).”
BackgroundExercise-induced histone acetylation - playing tag with the genome
Saleem, A., & Safdar, A. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2009.185595 · Cited by 8
New Insights into the Mechanisms Underlying NEDD8 Structural and Functional Specificities
Santonico, E. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.83426 · Cited by 9
“16 p53, promoted by Mdm2 low levels, is sufficient for nuclear export, whereas high levels of Mdm2 activity induce p53’s polyubiquitination and proteasome-dependent degradation [81].”
BackgroundMaki, C. G. (2010) · Molecular biology intelligence unit · doi:10.1007/978-1-4419-8231-5_8 · Cited by 11
Gatekeepers of the Guardian: p53 Regulation by Post-Translational Modification, MDM2 and MDMX
Wahl, G. M., Stommel, J. M., Krummel, K. A., & Wade, M. R. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_4 · Cited by 10
“, 2001), or poly-ubiquitination of p53 (Li et al., 2003).”
BackgroundInfluentialAuger, K. R., Copeland, R. A., & Lai, Z. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)99046-0 · Cited by 9
Posttranslational Modification and Cell Type-Specific Degradation of Varicella-Zoster Virus ORF29p
Stallings, C. L., & Silverstein, S. J. (2006) · Journal of Virology · doi:10.1128/jvi.00966-06 · Cited by 7
MDM2 RNA binding is blocked by novel monoclonal antibody h-mdm2-F4-14
Anderson, J., Challen, C., Atkins, H., Suaeyun, R., Crosier, S., & Lunec, J. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.3.545 · Cited by 7
Liu, C., Li, Q., Shen, Z., Xia, R., Chen, Q., Li, X., Ding, Y., Yang, S., Serino, G., Xie, Q., et al. (2024) · New Phytologist · doi:10.1111/nph.20224 · Cited by 6
Metadata
- Authors
- Li, M., Brooks, C. L., Wu-Baer, F., Chen, D., Baer, R., & Gu, W.
- Affiliations
- Columbia University (US)
- Corresponding author
- Gu, Wei
- Venue
- Science
- Published
- 2003-12-12
- Volume
- 302
- Issue
- 5652
- Pages
- 1972-1975
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2050745715
- Cited by
- 804
- References
- 30
- Citations by year
- 2026: 6 · 2025: 15 · 2024: 21 · 2023: 21 · 2022: 24 · 2021: 25 · 2020: 28 · 2019: 22 · 2018: 22 · 2017: 24 · 2016: 32 · 2015: 34 · 2014: 45 · 2013: 37 · 2012: 38
- FWCI
- 19.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53, MDM2, monoubiquitination, polyubiquitination, ubiquitination, p53 degradation, tumor suppressor regulation
- MeSH terms
- Animals, Cell Nucleus, Cells, Cultured, Cytoplasm, Humans, Mutation, Nuclear Proteins, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Transfection, Tumor Suppressor Protein p53, Mice, Knockout, Protein Transport, Active Transport, Cell Nucleus, Ubiquitin, Cell Line, Tumor, Mice, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.